Related Experiment Video
Updated: May 7, 2026
06:32
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Post-chemotherapy maturation in supratentorial primitive neuroectodermal tumors.
Lucie Lafay-Cousin1, Walter Hader, Xing Chang Wei
1Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Alberta Children's Hospital, Calgary, Alberta, Canada.
Brain Pathology (Zurich, Switzerland)
|September 17, 2013
Summary
Histological maturation in central nervous system embryonal tumors is rare. This report details two supratentorial primitive neuroectodermal tumor cases with maturation, highlighting varied outcomes and treatment implications.
Area of Science:
- Neuro-oncology
- Developmental Neuroscience
- Tumor Biology
Background:
- Maturation is an uncommon event in central nervous system embryonal tumors.
- It is primarily documented in specific medulloblastoma subgroups.
- Understanding maturation in other embryonal tumors is crucial.
Observation:
- Two cases of supratentorial primitive neuroectodermal tumor (sPNET) exhibiting histological maturation were identified.
- These cases presented with markedly different clinical outcomes.
- The observed maturation patterns varied between the two patients.
Findings:
- Histological maturation can occur in sPNET, a rare finding.
- The presence and extent of maturation may correlate with patient outcome.
- Distinct maturation pathways might exist within sPNET.
Implications:
- Maturation findings in sPNET could influence treatment strategies.
- This phenomenon may offer new insights into tumor progression and regression.
- Further research is warranted to elucidate the prognostic significance of maturation in sPNET.
